Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 1 49-1, 2004, Pages

  Wang, Hua ^a   Chu, Winston S ^a   Lu, Tong ^a   Hasstedt, Sandra J ^b   Kern, Philip A ^a   Elbein, Steven C ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Association study; Gene expression; Insulin sensitivity; Single nucleotide polymorphism

Indexed keywords

INSULIN; MESSENGER RNA; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2;

3' UNTRANSLATED REGION; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0346787545     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00231.2003     Document Type: Article

References (38)

1. Allison DB, Faith MS, and Nathan JS. Risch's lambda values for human obesity. Int J Obes Relat Metab Disord 20: 990-999, 1996.
2. Allison DB, Heo M, Kaplan N, and Martin ER. Sibling-based tests of linkage and association for quantitative traits. Am J Hum Genet 64: 1754-1763, 1999.
3. Argyropoulos G, Brown AM, Peterson R, Likes CE, Watson DK, and Garvey WT. Structure and organization of the human uncoupling protein gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes 47: 685-687, 1998.
4. Argyropoulos G and Harper ME. Uncoupling proteins and thermoregulation. J Appl Physiol 92: 2187-2198, 2002.
5. Bergman RN, Phillips LS, and Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467, 1981.
6. Bouchard C, Perusse L, Chagnon YC, Warden C, and Ricquier D. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet 6: 1887-1889, 1997.
7. Burton BT, Foster WR, Hirsch J, and Van Itallie TB. Health implications of obesity: an NIH Consensus Development Conference. Int J Obes 9: 155-170, 1985.
8. Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, and Nickerson DA. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet 33: 518-521, 2003.
9. Chan CB, De Leo D, Joseph JW, McQuaid TS, Ha XF, Xu F, Tsushima RG, Pennefather PS, Salapatek AM, and Wheeler MB. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50: 1302-1310, 2001.
10. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
11. Dalgaard LT and Pedersen O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia 44: 946-965, 2001.
12. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, Hanis CL, and Hasstedt SJ. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87: 650-654, 2002.
13. Elbein SC, Chu W, Ren Q, Wang H, Hemphill C, and Hasstedt SJ. Evaluation of apolipoprotein A-II as a positional candidate gene for familial Type II diabetes, altered lipid concentrations, and insulin resistance. Diabetologia 45: 1026-1033, 2002.
14. Elbein SC and Hasstedt SJ. Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: evidence for linkage of triglyceride levels to chromosome 19q. Diabetes 51: 528-535, 2002.
15. Elbein SC, Hasstedt SJ, Wegner K, and Kahn SE. Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 84: 1398-1403, 1999.
16. Elbein SC, Hoffman MD, Teng K, Leppert MF, and Hasstedt SJ. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48: 1175-1182, 1999.
17. Elbein SC, Leppert M, and Hasstedt S. Uncoupling protein 2 region on chromosome 11q13 is not linked to markers of obesity in familial type 2 diabtetes. Diabetes 46: 2105-2107, 1997.
18. Elbein SC, Sun J, Scroggin E, Teng K, and Hasstedt SJ. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes. Diabetes Care 24: 472-478, 2001.
19. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, and Patsch W. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28: 178-183, 2001.
20. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, and Warden CH. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15: 269-272, 1997.
21. Fleury C and Sanchis D. The mitochondrial uncoupling protein-2: current status. Int J Biochem Cell Biol 31: 1261-1278, 1999.
22. Hasstedt SJ. PAP: Pedigree Analysis Package, V5. Salt Lake City, UT: University of Utah, Dept. of Human Genetics, 2001.
23. Hasstedt SJ, Hoffman M, Leppert MF, and Elbein SC. Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes. Am J Hum Genet 61: 668-677, 1997.
24. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, and Bell GI. Genetic variation in the gene encoding calpain 10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163-175, 2000.
25. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, and Porte D Jr. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42: 1663-1672, 1993.
26. Kern PA, Ranganathan S, Li C, Wood L, and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity-associated insulin resistance. Am J Physiol Endocrinol Metab 280: E745-E751, 2001.
27. Krempler F, Esterbauer H, Weitgasser R, Ebenbichler C, Patsch JR, Miller K, Xie M, Linnemayr V, Oberkofler H, and Patsch W. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 51: 3331-3335, 2002.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
29. Ott J. Computer-simulation methods in human linkage analysis. Proc Natl Acad Sci USA 86: 4175-4178, 1989.
30. Ott J. Analysis of Human Genetic Linkage (3rd ed.). Baltimore, MD: Johns Hopkins Univ. Press, 1999.
31. Ranganathan G and Kern PA. In vitro transcription and translation of lipoprotein lipase. Methods Mol Biol 109: 337-341, 1999.
32. Risch N and Merikangas K. The future of genetic studies of complex human diseases. Science 273: 1516-1517, 1996.
33. Saleh MC, Wheeler MB, and Chan CB. Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia 45: 174-187, 2002.
34. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del Guerra S, Lauro D, De Nicolais P, Sbraccia P, Del Prato S, Gambardella S, Federici M, Marchetti P, and Lauro R. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 52: 1280-1283, 2003.
35. Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP, Easlick J, Warden CH, Pecqueur C, Raimbault S, Ricquier D, Silver MHK, Shuldiner AR, Solanes G, Lowell BB, Chung WK, Leibel RL, Pratley R, and Ravussin E. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. Hum Mol Genet 7: 1431-1435, 1998.
36. Wang H, Chu W, Hemphill C, Hasstedt SJ, and Elbein SC. Mutation screening and association of human retinoid X receptor gamma variation with lipid levels in familial type 2 diabetes. Mol Genet Metab 76: 3-12, 2002.
37. Weyer C, Bogardus C, Mott DM, and Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104: 787-794, 1999.
38. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, and Lowell BB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105: 745-755, 2001.